HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Pol(283-290) | Pol Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
TAFTIPSI
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Species (MHC/HLA) | human(B*51:01) |
Showing all: 2 variant(s).
Variant ID. | 1315 |
---|---|
Epitope Seq. | TAFTIPSI |
Variant Seq. | TAFTIPSx |
Mutations | I/X |
Epitope Location | I8X |
HXB2 Location | I290X |
Mutation Type | E: escape documented in this paper |
Method | HLA binding, Sequence |
Note | 98% of subjects in an HLA-B*5101 cohort carried this I135x escape. It is suggested that it is selected during the acute phase of infection rather than at transmission or at chronic infection. |
Variant ID. | 2218 |
---|---|
Epitope Seq. | TAFTIPSI |
Variant Seq. | TAFTIPSt |
Mutations | I/T |
Epitope Location | I8T |
HXB2 Location | I290T |
Mutation Type | CHB: calculated diminished HLA binding OV: observed variant |
Method | Sequence |
Note | The predominant substitution in this epitope is I135t. Binding of this mutant to HLA-B*5101 would be abrogated in vivo as per binding association studies. |
Moore2002b Corey B. Moore, Mina John, Ian R. James, Frank T. Christiansen, Campbell S. Witt, and Simon A. Mallal. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science, 296(5572):1439-1443, 24 May 2002. PubMed ID: 12029127. Show all entries for this paper.